Companies: 10,795·Total market cap: $144.5T
Fulgent Genetics, Inc.

Fulgent Genetics, Inc.

FLGTNASDAQHealthcare● Active
$18.69
$-0.46(-2.38%)
Market Cap$530935447
P/E Ratio
52W High$31.04
52W Low$13.46
Overview

Fulgent Genetics, Inc. (FLGT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · FLGT · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.38flgt eps ttm · flgt earnings per shareEarnings history
PE Ratio (TTM)flgt pe ratio ttm · flgt price to earningsPE Ratio deep dive
Revenue (TTM)$320.3Mflgt revenue ttm · flgt annual revenueFull revenue history
Dividend YieldNo Dividenddoes flgt pay dividends · flgt dividend yieldDividend history
Shares Outstanding30.8Mflgt shares outstanding · flgt floatShares outstanding history
Next EarningsJul 31, 2026Est.flgt earnings date · flgt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$322.7M▲ +13.83% YoY
202320242025
fulgent genetics, inc. revenue · flgt revenue 2025
FY 2025Net Income-$60.5M▼ 41.69% YoY
202320242025
fulgent genetics, inc. net income · flgt profit 2025
FY 2025EPS$-1.97▼ 39.72% YoY
202320242025
flgt eps · fulgent genetics, inc. earnings per share 2025
TTM:Revenue: $320.3MNet Income: -$73.8MEPS: $-2.38View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy9 analystsis flgt a buy · flgt analyst rating
Strong Buy
0
Buy
6
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$15.00Low
$18.69Current
$15.00Avg Target19.76% downside
$15.00High
flgt price target · flgt 12 month forecast

Total: 9 · Buy rate: 66.7%

The FLGT analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $15.00, representing -19.76% downside from the current price of $18.69.

Stock Performance

Full History
1D-2.40%
1W+0.48%
1M+17.11%
3M+27.75%
YTD-28.85%
1Y-14.31%
5Y-77.73%

About Fulgent Genetics, Inc.

CEOMing Hsieh
IPO DateSep 29, 2016
Employees1,313
CountryUS

Fulgent Genetics, Inc. together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The c…

what is fulgent genetics, inc. · flgt stock overview · fulgent genetics, inc. company profile · who is fulgent genetics, inc. ceo · flgt NASDAQ · fulgent genetics, inc. headquarters · fulgent genetics, inc. business segments

About Stock Overview & Key Data

Fulgent Genetics, Inc. (FLGT) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Sep 29, 2016. As of the latest trading session, FLGT stock price is $18.69, with a market capitalization of $530.9M. The stock has returned -14.31% over the past 12 months and -28.85% year-to-date.

According to 9 Wall Street analysts, the consensus rating for Fulgent Genetics, Inc. stock is Buy, with an average 12-month price target of $15.00. In fiscal year 2025, Fulgent Genetics, Inc. reported revenue of $322.7M and net income of -$60.5M. For detailed data — including Fulgent Genetics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Fulgent Genetics, Inc. (FLGT) stock price is $18.69. The stock is traded on NASDAQ under the ticker symbol FLGT. The 52-week range is $13.46 – $31.04.

FLGT stock priceFLGT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice